NCT05359003Completed
Steps for Epilepsy
A Feasibility Study of a Step-goal Based Physical Activity Intervention in People With Epilepsy
Source: ClinicalTrials.gov · Last updated 8 Jan 2026
Brief summary (registry, in English)
The purpose of this research study is to evaluate the feasibility of a 12-week, telehealth delivered, step-goal based physical activity intervention in people with epilepsy. The study team will also evaluate the physical activity profiles of people with epilepsy both at rest and when engaged in physical activity and gather information on the effect of the intervention on epilepsy and epilepsy associated comorbidities.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 26 (actual)
- First submitted
- 28 Apr 2022
- Start date
- 13 Feb 2023
- Primary completion date
- 1 Oct 2024
- Lead sponsor
- Wake Forest University Health Sciences
- Diseases
- Epilepsy
- NCT number
- NCT05359003
What you commit to
- Study type: Interventional
- Participants enrolled: 26
- From 13 Feb 2023 to the primary completion date, 1 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Seizures associated with falls with injury (such as atonic seizures)
- Medical conditions that would limit ability to participate in an exercise intervention including: Stage III or IV Congestive Heart Failure (CHF); End-stage Renal Disease; Severe dementia or significant cognitive impairment that precludes participation in the intervention or limits ability to follow the study protocol; Uncontrolled hypertension (HTN) defined as systolic blood pressure greater than 180 mmHg and diastolic blood pressure greater than 110 mmHg at rest; Severe arthritis, amputations, or orthopedic problems that limit ambulatory ability
- An active Central Nervous System (CNS) infection, demyelinating disease, degenerative neurologic disease or any CNS disease deemed to be progressive during the course of the study that may confound the interpretation of the study results
- Any clinically significant psychiatric illness, psychological, or behavioral problems that would interfere with the subject's ability to participate in the study.
- Participants who have \<75% complete days of seizure recording in the study diary or step data via the Garmin device will not be randomized.
Other
- Diagnosis of nonepileptic or psychogenic spells
- Currently pregnant or plan to become pregnant during the study period (16 weeks)
- Unwilling or unable to comply with all study visits and procedures
Who the study is looking for
- Age 18 or older
- Focal or generalized epilepsy, as determined clinically by a WFBH epileptologist with no significant consideration of an alternative diagnosis
- Access to a smartphone with application capabilities
- Internet access or cellular data plan to attend virtual sessions
- Able to ambulate independently
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Atrium Health Wake Forest Baptist Coordinator of this site? Confirm its status | Winston-Salem | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.